Barclays
WST icon

Barclays’s West Pharmaceutical WST Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$43.7M Buy
199,588
+7,412
+4% +$1.62M 0.01% 564
2025
Q1
$43M Buy
192,176
+51,044
+36% +$11.4M 0.01% 526
2024
Q4
$46.2M Sell
141,132
-114,053
-45% -$37.4M 0.01% 499
2024
Q3
$76.6M Buy
255,185
+83,710
+49% +$25.1M 0.02% 412
2024
Q2
$56.5M Buy
171,475
+20,815
+14% +$6.86M 0.02% 451
2024
Q1
$59.6M Sell
150,660
-25,556
-15% -$10.1M 0.02% 457
2023
Q4
$62M Buy
176,216
+18,220
+12% +$6.42M 0.02% 433
2023
Q3
$59.3M Buy
157,996
+27,264
+21% +$10.2M 0.04% 409
2023
Q2
$50M Buy
130,732
+60,041
+85% +$23M 0.03% 437
2023
Q1
$24.5M Sell
70,691
-24,767
-26% -$8.58M 0.01% 547
2022
Q4
$22.5M Buy
95,458
+16,704
+21% +$3.93M 0.01% 608
2022
Q3
$19.4M Buy
78,754
+689
+0.9% +$170K 0.02% 597
2022
Q2
$23.6M Sell
78,065
-70,684
-48% -$21.4M 0.01% 525
2022
Q1
$61.1M Buy
148,749
+7,575
+5% +$3.11M 0.05% 353
2021
Q4
$66.2M Buy
141,174
+25,701
+22% +$12.1M 0.02% 357
2021
Q3
$49M Sell
115,473
-654
-0.6% -$278K 0.02% 409
2021
Q2
$41.7M Buy
116,127
+19,099
+20% +$6.86M 0.02% 465
2021
Q1
$27.3M Buy
97,028
+29,082
+43% +$8.19M 0.01% 537
2020
Q4
$19.2M Buy
67,946
+6,707
+11% +$1.9M 0.01% 578
2020
Q3
$16.8M Buy
61,239
+7,762
+15% +$2.13M 0.01% 569
2020
Q2
$12.2M Buy
53,477
+13,497
+34% +$3.07M 0.01% 586
2020
Q1
$6.09M Sell
39,980
-42,691
-52% -$6.5M ﹤0.01% 785
2019
Q4
$12.4M Sell
82,671
-17,681
-18% -$2.66M 0.01% 762
2019
Q3
$14.2M Buy
100,352
+72,629
+262% +$10.3M 0.01% 660
2019
Q2
$3.47M Sell
27,723
-11,026
-28% -$1.38M ﹤0.01% 1352
2019
Q1
$4.27M Buy
38,749
+19,498
+101% +$2.15M ﹤0.01% 1055
2018
Q4
$1.89M Sell
19,251
-6,592
-26% -$646K ﹤0.01% 1397
2018
Q3
$3.19M Buy
25,843
+20,284
+365% +$2.51M ﹤0.01% 1404
2018
Q2
$553K Sell
5,559
-24,957
-82% -$2.48M ﹤0.01% 2213
2018
Q1
$2.7M Buy
30,516
+27,709
+987% +$2.45M ﹤0.01% 1208
2017
Q4
$277K Buy
2,807
+1,861
+197% +$184K ﹤0.01% 2466
2017
Q3
$92K Sell
946
-10,252
-92% -$997K ﹤0.01% 2727
2017
Q2
$1.06M Buy
11,198
+1,057
+10% +$99.9K ﹤0.01% 1533
2017
Q1
$827K Buy
10,141
+2,814
+38% +$229K ﹤0.01% 1669
2016
Q4
$621K Buy
7,327
+4,113
+128% +$349K ﹤0.01% 1728
2016
Q3
$239K Sell
3,214
-18,438
-85% -$1.37M ﹤0.01% 2044
2016
Q2
$1.64M Buy
21,652
+20,874
+2,683% +$1.58M ﹤0.01% 1200
2016
Q1
$53K Sell
778
-2,838
-78% -$193K ﹤0.01% 2511
2015
Q4
$217K Buy
3,616
+2,387
+194% +$143K ﹤0.01% 2009
2015
Q3
$66K Sell
1,229
-193
-14% -$10.4K ﹤0.01% 2500
2015
Q2
$83K Sell
1,422
-739
-34% -$43.1K ﹤0.01% 2436
2015
Q1
$129K Sell
2,161
-3,725
-63% -$222K ﹤0.01% 2419
2014
Q4
$312K Sell
5,886
-3,260
-36% -$173K ﹤0.01% 2184
2014
Q3
$402K Buy
9,146
+7,877
+621% +$346K ﹤0.01% 2045
2014
Q2
$54K Sell
1,269
-1,597
-56% -$68K ﹤0.01% 3001
2014
Q1
$125K Sell
2,866
-63,008
-96% -$2.75M ﹤0.01% 2648
2013
Q4
$3.23M Buy
65,874
+18,016
+38% +$883K ﹤0.01% 1172
2013
Q3
$1.96M Buy
47,858
+12,409
+35% +$509K ﹤0.01% 1296
2013
Q2
$2.49M Buy
+35,449
New +$2.49M ﹤0.01% 1193